Overexpression of ubiquitin-specific peptidase 15 in systemic sclerosis fibroblasts increases response to transforming growth factor β by Galant, C, Marchandise, J, Stoenoiu, MS, Ducreux, J, De Groof, A, Pirenne, S, Van Den Eynde, B, Houssiau, FA, Lauwerys, BR

Toll-like receptor 3 increases antigen-presenting cell responses to a pro-apoptotic stimulus, yet does not contribute to systemic lupus erythematosus genetic susceptibility by De Groof, A, Ducreux, J, Vidal-Bralo, L, Tyteca, D, Galant, C, Marot, L, Coulie, PG, Van den Eynde, BJ, Rodriguez-Martinez, L, Santos, MJ, Suarez, A, Carreira, P, Marchini, M, Gonzàlez, A, Houssiau, FA, Lauwerys, BR

Establishing surrogate kidney endpoints for lupus nephritis clinical trials: development and validation of a novel approach to predict future kidney outcomes by Mackay, M, Dall’Era, M, Fishbein, J, Kalunian, K, Lesser, M, Guerrero, J, Levy, DM, Silverman, E, Petri, M, Arriens, C, Lewis, EJ, Korbet, SM, Conti, F, Tesar, V, Hruskova, Z, Borba, EF, Bonfa, E, Chan, T, Rathi, M, Gupta, KL, Jha, V, Hasni, S, West, MR, Silverman, E, Solomons, N, Houssiau, FA, Diaz, J, Mejia-Vilet, J, Rovin, BH